Issue link: http://www.e-digitaleditions.com/i/579724
Inhalation OCTOBER2015 21 Wide range of inhalation solutions Catalent, a global leader for inhaled drug product development and man- ufacturing, provides a broad range of inhalation solutions. Catalent's inhalation capabilities span API optimization, particle-size engineering, pre-formulation, formulation, analytical testing, device evaluation and selection, and clinical and commercial manufacturing across inhaled dosage forms including: pressurized metered dose inhalers (pMDIs), dry powder inhalers (DPIs), nasal sprays (solutions/suspensions), and nebu- lizers and liquid inhalers. For more than 20 years, Catalent's deep exper- tise, end-to-end solutions and reliable execution have been successfully applied to all primary inhaled dosage forms to accelerate drug develop- ment programs and bring better treatments to patients worldwide. Catalent Pharma Solutions US: +1 877 587-1835 www.catalent.com Comprehensive particle characterization services Gateway Analytical provides comprehensive particle characteriza- tion services to identify the physical and chemical properties of the active ingredient and excipient components within a final formula- tion. Gateway's methods provide chemically-specific data on each particle, which allows them to easily identify and separate active ingredient from the excipients, and identify multiple active ingre- dients in more complex formulations. In addition, Gateway Ana- lytical supports quality testing by providing an array of services for foreign particulate identification and contaminant source determi- nation. Gateway Analytical US: +1 724 443-1900 www.gatewayanalytical.com SPECIAL SECTION Broad inhalation technology platform Capsugel continues to expand its capabilities for the design and development of inhalation-based drug products. With a unique combination of particle engi- neering through its spray drying (SD) technology and customized DPI capsules, Capsugel is able to provide customers with world-class formulation design, encapsulation expertise and a rapid to clinic DPI development platform. Cap- sugel's Bend Research division has customized SD processing equipment which, combined with early formulation and process development knowledge, enables rapid scale-up from hundreds of mg to kg quantities of drug product using a bulk API-sparing method. Its SD technology is highly flexible and can be used to pro- duce crystalline and amorphous materials to meet a wide range of delivery and API profiles. Capsugel US: +1 864 942-3063 www.capsugel.com Outsourcing This section of Inhalation provides informa- tion that may be useful in research and development or manufacturing. Content is provided by the companies listed. No prod- uct endorsement or preference is intended.